On March 18, 2021 Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, reported that Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics, will present at the following upcoming virtual conferences (Press release, Cytori Therapeutics, MAR 18, 2021, View Source [SID1234576845]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event BIO-Europe Spring Digital 2021
Date March 22-25, 2021
Presentation Available on demand beginning March 22

Event Q1 Virtual Investor Summit
Date March 23-25, 2021
Presentation March 23, 2021 at 11:30 a.m. ET

Investors interested in arranging a meeting with the Company’s management for these conferences should contact the respective conference coordinator.

Webcasts of the conference presentations will be available under the ‘Events’ tab of the Investor Relations section of the Plus Therapeutics website at www.plustherapeutics.com.